Reuters logo
BRIEF-ProMIS Neurosciences announces private placement
February 6, 2017 / 12:47 PM / in 8 months

BRIEF-ProMIS Neurosciences announces private placement

Feb 6 (Reuters) - ProMIS Neurosciences Inc

* ProMIS Neurosciences announces private placement

* ProMIS Neurosciences Inc says it is offering, on a private placement basis, up to 14 million units at price of CDN$0.145 per unit

* ProMIS Neurosciences - net proceeds of offering will be used to advance co’s alzheimer disease portfolio, including development of lead product PMN 310

* ProMIS Neurosciences - net proceeds to be used to initiate development of effective ad diagnostics for detection of toxic prion strains

* ProMIS Neurosciences Inc - net proceeds of offering will be used to develop Promis’ TAU and TDP43 assets for dementias and ALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below